Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR5 | P32302 | 20/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3633568 | 0.92 | CXCR5 (0.85) | CXCR5 | |
| SCHEMBL3304519 | 0.85 | CXCR5 (0.76) | CXCR5 | |
| SCHEMBL3312934 | 0.83 | CXCR5 (1.00) | CXCR5 | |
| SCHEMBL3309007 | 0.83 | CXCR5 (0.61) | CXCR5 | |
| SCHEMBL3306765 | 0.81 | CXCR5 (0.78) | CXCR5 | |
| SCHEMBL3309706 | 0.75 | CXCR5 (0.79) | CXCR5 | |
| SCHEMBL3309731 | 0.74 | CXCR5 (1.00) | CXCR5 | |
| SCHEMBL3306951 | 0.73 | CXCR5 (0.77) | CXCR5 | |
| SCHEMBL3304472 | 0.70 | CXCR5 (1.00) | CXCR5 | |
| SCHEMBL13328299 | 0.70 | CXCR5 (0.70) | CXCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2155711-A1 | SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS | Sanofi-Aventis (FR) | 2010-02-24 | — | — | EP | claimed |
| WO-2008151211-A1 | SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS | SANOFI-AVENTIS (FR) | 2008-12-11 | — | — | WO | claimed |
| EP-2155711-A1 | SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS | Sanofi-Aventis (FR) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008151211-A1 | SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS | SANOFI-AVENTIS (FR) | 2008-12-11 | — | — | WO | disclosed |